The Curcumin Analog C-150, Influencing NF-κB, UPR and Akt/Notch Pathways Has Potent Anticancer Activity in Vitro and in Vivo

[vc_row][vc_column][vc_message]Hackler L Jr, Ózsvári B, Gyuris M, Sipos P, Fábián G, Molnár E, Marton A, Faragó N, Mihály J, Nagy LI, Szénási T, Diron A, Párducz Á, Kanizsai I, Puskás LG.[/vc_message][vc_column_text]

Abstract

C-150 a Mannich-type curcumin derivative, exhibited pronounced cytotoxic effects against eight glioma cell lines at micromolar concentrations. Inhibition of cell proliferation by C-150 was mediated by affecting multiple targets as confirmed at transcription and protein level. C-150 effectively reduced the transcription activation of NFkB, inhibited PKC-alpha which are constitutively over-expressed in glioblastoma. The effects of C-150 on the Akt/ Notch signaling were also demonstrated in a Drosophila tumorigenesis model. C-150 reduced the number of tumors in Drosophila with similar efficacy to mitoxantrone. In an in vivo orthotopic glioma model, C-150 significantly increased the median survival of treated nude rats compared to control animals. The multi-target action of C-150, and its preliminary in vivo efficacy would render this curcumin analogue as a potent clinical candidate against glioblastoma.[/vc_column_text][cz_title id=”cz_78175″ cz_title=””]

Figures

[/cz_title][/vc_column][/vc_row][vc_row][vc_column width=”1/3″][vc_single_image image=”114″ img_size=”medium” alignment=”center” onclick=”link_image”][/vc_column][vc_column width=”1/3″][vc_single_image image=”113″ img_size=”medium” alignment=”center” onclick=”link_image”][/vc_column][vc_column width=”1/3″][vc_single_image image=”112″ img_size=”medium” alignment=”center” onclick=”link_image”][/vc_column][/vc_row]